The largest running ovarian cancer screening study, the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) [3], has evaluated multi-modal screening in post-menopausal women based on indications of elevated MUCIN-16 (Cancer antigen-125/CA125) followed by transvaginal ultrasound (TVU). Here, MUC16 is linked to ovarian cancer.